>> it's actually quite dramatically changing with team j&j. it's not just about a j&j booster. there is some intriguing data showing that if you get another vaccine type for your second shot you make it more antibody response. it kind of goes with the fact that everybody is moving toward an mrna vaccine, so that will be my prediction for how this will play out eventually. kristen: what do you think will play out eventually? do you think it is slightly -- likely that may just scrap j&j and just recommend that those who got j&j will get moderna or pfizer? >> right now j&j has some nice data showing that if you get a booster is kind of like line, it gets better with time. a few weeks later, four weeks looks better and 12 weeks looks even better, but the study is very compelling. if you followed up with the moderna booster, your 76 times higher antibody levels, and four times higher if you got a second shot with j&j. kristen: that is compelling. what about the reverse, james wants to know, i got moderna, both injections. can i get a j&j booster? is there any reason to? >> the reaso

j. >> yeah, cheryl. this could have been much worse. again, cheryl hurd reporting in oakland. tenth and market there, that ac transit bus careening into that home. darryl, the homeowner there, inside. thankfully he is okay. thank you, cheryl. >>> what else is happening tonight? well, booster shots. j&j is now in play. should you get one? are you even eligible? and if so, when? we have some answers. today the fda clearing up the confusion for anyone who received that johnson & johnson vaccine. remember, that was the single-dose vaccine. an fda panel unanimously voted to authorize boosters for those who got the j&j shot. here are the specifics. no real age restrictions here. you can get the j&j booster if you're 18 or older. >> we wanted to provide optimal protection against covid. we know that a booster dose will do that. >> here's the timeline. a couple more things need to happen. the fda needs to give final approval. the cdc hearingweek. if the cdc gives its recommendation shots could s

than if you boosted with j&j. again, let's be clear. these are indications of what your likely protection is but measures of antibodies we know correlate but are not perfect. yeah. a lot of people with that data would say, hmm, maybe if i got j&j, like my two grandkids did and i need a booster, maybe i'll switch over. fda didn't ask their advisory committee to vote on that, just discuss it. we'll see what happens over the course of the next week. remember, this comes to cdc next week. their advisory committee on immunization practices. they'll look at the same data. maybe by end of next week we'll have a consensus about what to say with regard to the question you just asked, about boosters for j&j. >> please, come back. we'll talk more about it. are we going to need booster shots for covid every year, kind of like we do with the flu now? >> hallie, nobody knows. keep in mind, of course, we didn't know about this virus until 22 months ago's we are learning as we go along and trying to do everything we can to acquir

j axing get a second shot. it comes afternoon research that shows antibody levels from the vaccine were substantially lower compared to the two mrna vaccines. the u.s. health regulator is also considering whether to lower the age range for the booster shots. joining me now is the dean of brown university school of public health. thank you so much for being with us. before we get into the recommendations, how concerned are you with the fact that the country is trying to get more vaccinated, but the guidance keeps changing and people are more confused than ever? >> thank you for having me back. i am concerned that the communication around vaccines and boters has not been as clear as it eds to be. if you are unvaccinated in america, you need to get vaccinated. the delta variant is dangerous and unvaccinated people need to get the first shot. that doesn't mean we shouldn't also be talking about boosters. boosters are an important tool for particularly high risk people. >> i want to focus on the j&j vaccine. new res

the focus is today on j&j. this as a giant study of veterans show vaccine protection does weaken after six months or so, and we begin right there with your health and with an fda advisers vaccine meeting that's happening right now. today's agenda is to decide whether to authorize a booster for those who receive johnson & johnson's vaccine. this gave a green light to moderna and pfizer boosters so this is expected for j&j as well and a new study shows that mixing and matching vehicles evens and boosters between the three different vaccine brands seems to work well. our senior medical correspondent elizabeth cohen joins us to kick this off. we expect a green light for j&j and put this big decision into context. >> we do expect a green light for j&j, john, for the reasons that they gave a green light to pfizer, for reasons that this expert panel yesterday gave a green light to moderna that boosters do seem to be effective six months after the original shots, but for j&j it may be especially important. i had a conv

j? >> absolutely, thank you. >> thank you everybody for joining and i hope everybody has a good weekend and we look forward to seeing you next week. thank you. >> business officials testified about small business supply chain issues before a house subcommittee. march tonight 8:00 p.m. eastern on c-span2, online@c-span.org or are new video app, c-span now. ♪♪ >> book tv onto sunday's, leading authors for latest nonfiction books 2:00 p.m. eastern, the 33rd annual southern festival books from nashville. virtual event features, jesus john wade. tennessee cover bill discussing his book, facebook presence. 10:00 p.m. on "afterwards", california congressman and adam schiff talks about midnight in washington. he accounts his role in president terms first impeachment trial with threats against american democracy interviewed by associated press chief congressional correspondent, lisa. watch book tv every sunday on c-span2. find a full schedule on your program guide, watch online anytime booktv

if you had the j&j vaccine, you can get the j&j booster. anyone over the age of 18 or older. no restrictions. as for moderna, the fda advisory panel is recommending a half-dose booster six months after you got your second one. anyone 65 and older or people that are at high risk of severe disease because of health conditions or because of exposure at your job. now, the pfizer booster is already available for people in those same subgroups. >>> new details tonight concerning president clinton. he'll remain in an orange county hospital tonight recovering from a your logical infection that spread to his bloodstream. the 75-year-old former president was admitted to uc irvine medical center on tuesday night. doctors say he is responding well to antibiotics and that his white blood count cell count is trending down. now, experts say that kind of infection, not unusual for seniors. mr. clinton, by the way, underwent a quadruple bypass back in 2004. >>> re-opening the u.s. border starting november 8th. vaccinated travelers can enter the u.s. that means allowing in people from 33 count

j, the one shot j&j. clearly you need to be taking it seems like either pfizer or, betteriest, moderna based on the data but just to clarify, those who have taken the pfizer or moderna when they think about the booster, you would not be taking necessarily a j&j booster. >> right and there are several reasons for that, andrew, just, number one, i do think if you look at the data, you will see that especially, for example, moderna recipient that you started with moderna, it's still incredibly effective to stick with that mrna category and with that mate na and pfizer set, i'm bringing up the fact if we didn't have enough in that population, it wasn't powered to necessarily look for some of the safety signals. they didn't see anything, small population and i just don't want to go back to those dark days of j&j in the initial weeks we start to pause and see the clinical guidance around j&j, to warn people, especially about the risks. they still apply in a booster setting. so those are all reasons, mrna, stick

j? >> absolutely, thank you. >> thank you

antibody levels from the original j&j dose. upwards, shep, of 75 times now, how much antibody do we need probably not that much i think it is clear it is better than a second dose it brings up for me in practical patient conversations yes an mrna vaccine might suit you better for that second dose. i know a lot of my patients are seeking out though, shep, a lot of my pfizer patients saying i want the moderna one we don't see that much incremental difference if you have one mrna to switch to the other and i would say it is not worth switching if it is easy to stick with the same manufacturer you're hitting it on the point on j&j recipients. >> one more thing. i've been watching the numbers really closely in the united kingdom and i don't understand it they're well vaccinated yet their numbers are going up should we be concerned about this side of the pond? >> shep, this is something i've been watching closely and i have a little bit of a pang in my gut because we're watching a sub lineage of the delta strain, something very speci

of 90% except a j&j boost to an original j&j shot. what's not clear is what the fda and cdc will do with this. they only looked at antibody responses. another arm of the immune system, t cells are important in its vaccine's protection in meetings this week the fda has only asked advisers whether to recommend boosters for moderna and j&j of the same vaccine type on friday afternoon they'll discuss the mix and match results. next week the cdc's advisers are meeting on boosters as well. it's possible they'll make a recommendation then. separately today, we got to see how the fda is looking at j&j's booster itself they're looking at a boost given at two months and whether stretching that out to six months might work better the fda said it didn't have enough time with j&j's data to conduct its own independent review but the company's results suggest there may be a benefit to a booster at two months there were some limitations to the available data as well, including how well a booster works with people over age 60 and how well it works ove

people need to understand that j&j against j&j from trial and the data they presented is based on clinical data. what you're going to see without a doubt is that the fda's going to take all of that under advisement and make a regulatorl get to the cdc with their advisory committee. they will make a recommendation and i believe there's going to be a degree of flexibility for someone who got j&j originally come over they can do. either with j&j or with the mix-and-match from other products. >> chris: let's take a look at where we are in this fourth wave of the coronavirus. there's an average of almost 84,000 new cases every day and more than 1500 deaths every day. still bad, but down considerably from a month ago. are we coming out of the delta wave? as we headed into colder weather, people going inside, holiday travel, what is the real possibility that we could have a fifth weight of the virus? especially, if there isn't a spike in the vaccinations? >> dr. fauci: that's for the problem come at you just mentioned. it's going to be within her capability. you're right. cases are down 23% of ho

j? >> absolutely, thank you. >> thank you announcer: c-span is your unfiltered view of government. we are funded by these television companies and more including comcast. >> do you think this is just a community center? it is more than that. >> comcast is partnering with community centers to create wi-fi live so students from low-income families can get the tools they need to be ready for anything. announcer: comcast support c-span is a public service along with these other television providers, having you a front row seat to democracy. ♪ announcer: c-span's "washington journal," every day taking your calls live on the air on the news of the day and discussing policy issues that impact you. coming up saturday morning, dave jamison discusses worker strikes taking place across the united states, and in our spotlight on magazine segment, the american conservative union foundation talks about his efforts to clear the records of x offenders seeking employment. watch c-span's "washington jou

we saw clinical data from j&j themselves, when you boost the j&j with a j&j vaccine, that you actually get really good effectiveness there as well. so that is really why we left it to the people, because quite honestly, most people did really well with their initial vaccine series. the vast majority of people did really well. we have 410 million people who have been vaccinated or 410 million vaccines have been given so people may want to pick the one that they got before. however, if you want something else, we left that option up to you. chris: just briefly, though, according to the data, if you get the j&j booster after the j&j initial dose, it boosted your antibodies four-fold, if you got the moderna booster after j&j it boosted antibodies 76-fold. i mean, if you were talking to your friend or a relative, it seems like it's a no-brainer. >> well, so we would have different kinds of data. that's data in the lab, an antibody response. we saw data in people, clinical effectiveness that deck straited a really good response to j&j as well. i i think i would leave it up to the clinical si

j route. what will likely happen is both the fda and their authorization and the cdc will likely give a degree of flexibility based on the individual's situation. >> and the adviser committee recommended the third dose of the moderna shot for those over 65 just like the pfizer shot as well. what's the timeline for expanding those categories to different age groups? >> well, that's a great question, martha. that's going to depend on the data that comes in because what we are dealing with, we are dealing with data rolling in in realtime not only from the cohorts that the cdc is following but also in realtime we are getting important data from israel because as i have said so often, israel is about a month or a month half of us temporarily with the vaccination and with the data that they're seeing about it is waning of immunity as well as the advantage of boosting people at different age groups. the data we are starting to see from israel indicates that even in the some what younger group from 40

some news for j&j, today it todt j&j submitted week data, what does that mean? >> this is why this is going to be important, they have submitted data and it may have been too soon as opposed to waiting for the full six months and the dead out was only looking at the level of antibodies there is not a lot of real-world data to show that the booster shot is needed in the johnson & johnson vaccine. we look at what the data companies put out there and realized this is an early press release, we want to see the fda coming through everything to make sure that the j&j shot with the j&j booster may not be better than getting a different booster. it obviously the company themselves are not going to put that forward. kristen: right. let's touch on this because it's related, a study today shows people who got the j&j vaccine initially they be helped more i other rands -- b and not its own. >> absolutely and this is what we were talking on with two truths. you and i have speculated about this for a while and this is not a new concept in vaccine science. heterologous immunit

j&j looks to be two months. moderna and j&j getting the boosters under u.s. fda authorization. caroline: it dovetails perfectly with the conversation we had with the president of howard university. we were talking about the vaccine policy over at the university, the way they managed most of their students. let's listen to what he had to say. >> we actually have students in all of our dorms. we and -- we have person instruction and a small number of students who stayed online. there are faculty teaching from home as well. this is homecoming week. having the students on campus is very different, and it is refreshing. they are wearing masks, following all the usual precautions among but it is definitely some much better to have them in person. romaine: do you require vaccinations? dr. frederick: we mandated vaccinations in our residence halls, 100%. we have some exemptions, but they can't stay in the residence halls. we did the same for faculty and staff. i would say people have been compliant. caroline: this has also been an economic and social crisis. i'm interested as to whethe

we also saw clinical data from j&j themselves that when you boost the j&j with the j&j vaccine, you get really good effecteffectiveness there as we. that's why we left it to the people because quite honestly, most people did really well with their initial vaccine series. the vast majority of people did really well and we have 410 million people who have been vaccinated, or for 10 million vaccines that have been given and so people want to pick the one that they got before but if you want something else, we left that option up to you. >> chris: it just briefly though, according to the data, if you get the j&j booster after you get the initial dose, it boosted your antibodies fourfold. if you got the moderna after the j&j at booster antibodies 76 fold. if you are talking to a friend or relative, it seems like it's a no brain are. >> chris: s>> dr. walensky: we'e different because of data but we saw people and clinical effectiveness that demonstrated a really good response to j&j as well. so i would leave it up to the clinical situation if i was talking to a specific person. if people want

increase with j&j. though the recommended moderna dosage was cut in half the numbers sparking conversations of mixing and matching vaccines. >> in general, we believe higher antibody is better that said, we don't know the exact correlative protection we don't know the magic number of antibody that means you won't get a coronavirus infection. >> reporter: dr. ofer levy sits on the panel that just recommended the j&j booster shot for all adults 18 and older two to six months after their initial dose >> currently there is no official way to get a mix and match short of misrepresenting to the health care provider what vaccine you got. >> reporter: the federal guidance currently says to stick with your original vaccine, even as some express skepticism about rolling up their sleeve in general. >> the point of the vaccination is to minimize your ability to contract the virus but then you're saying i take the vaccine, but i can still get the virus, so what's the real difference >> the main goal of these vaccine

j? >> yeah, look. sure. that's why he shouldn't have said it. that's why i agree he shouldn't have said it and that's why they walked it back and that's why doj was very, very strong in saying -- notwithstanding whatever the president said, we're going to make up our own minds. it was an unfortunate thing that he shouldn't have said. let's be clear and distinguish this from the kinds of things that happened under the prior administration where donald trump repeatedly to the extent anybody was making any connection there, repeatedly said publicly things that he wanted the justice department to do and not only that, as we're learning more and more, called people in the justice department to get them to do things up to and including overturning an election result in his favor. so i think biden's heart is in the right place, mind is in the right place. his tongue on one occasion today was not. >> i want to ask you about something on another front. a federal judge is blasting the treatment of

people need to understand that the j&j against the j&j from the trial and data they presented is based on clinical data. what you're going to see without a doubt is that the fda is going to take all of that under advisement from their advisory committee and they'll make a regulatory decision which we'll goat the cdc with their advisory committee and they'll make a recommendation. i believe there's going to be a degree of flexibility of what a person who got the j&j originally can do. either with j&j or with the mix and match from other products. chris: doctor, let's take a look at where we are now in this fourth wave of the coronavirus, there's an average of almost 84,000 new cases every day and more than 1500 deaths every day. still bad but down considerably from a month ago. are we coming out of the delta wave and as we head into colder weather, people going inside, holiday travel, what is the real possibility that we could have a fifth wave of the virus, especially if there's not a spike in vaccinations? >> well, that's the issue i think what you just mentioned just now, chris. it's

j the first time, and also authorized an extra dose of j&j. but if you look at the studies, the boosting that goes on is substantially higher, i moon substantially higher, when people who got an o.j. dose of j&j got either moderna or pfizer. so i think this is going to play out over the next week or so, but that's currently what the recommendations are. the fda is agnostic, doesn't care if you got j&j, whether you get j&j, pfizer, or moderna, but the data would suggest that you want to get a moderna or pfizer booster. >> all right. stay with the same brand. >> yeah. >> all right, dr. rutherford, thank you so much again. >> you bet. my pleasure, take care. bye-bye. >>> sonoma county could be the next to ease their indoor mask mandate. the county is considering allowing fully vaccinated residents to ditch wearing masks indoors. it will be in small sittings where the hosts or organizers can easily ask for proof of vaccinations. >>> this week marks 32 years since loma preetta, an earthquake that rocked the bay area and the state holds its yearly d

j j&j, pfizer? i think it's actually not jj&j. it's probably moderna or pfizer. if i don't have a clear feeling for how to boost each of these vaccines, how much can the average american who is not in medicine understand it. so i think if the fda and cdc are going to allow mixing and matching, they should give some guidance on which combinations make sense and when. >> if i got the johnson & johnson dose and research shows that moderna and pfizer's boosters might be stronger, why would anyone opt for the johnson & johnson booster? >> i think there's not a lot of reason to. if you look at -- there was one group of original folks who got the single dose j&j who had this increased risk of a rare cerebral venus thrombosis, important side effect, which makes one wonder whether anyone should get the second dose, particularly if you are a woman under the age of 50, which seem to be the highest risk group. and when you look at the data for the j&j boost, yeah, a second dose of j&j can increase the neutralizing antibodies by fourfold. but the moderna boost increased it by

j? there was that question of whether the j&j booster is the best for people who originally got j&j but a study out this week showed the j&j recipients had stronger immune responses with a pfizer or moderna booster. >> yes and no. first of all, the preponderance of data is in the court of doing the two-dose j&j vaccine, because those are bona fide phase 3 clinical trials. the problem with that preprint that came out two days ago, it's a great study, but it's tiny. it's 450 people, blind groups of 15 people each. and the study is done in a way that actually stacks the deck against measuring the effectiveness of a j&j booster versus the mrna. so even though there's a lot of press saying the mrna is a preferable booster to the j&j, it's not so cut and dry because the kinetics of the immune response of the j&j are such that there is a delayed effect, it goes up much later, and that study cut it off at 29 days whereas the higher vaccine effectiveness occurred 80 days or more. so there's going

if you got -- if you have j&j and then you decide to get another j&j as a booster. it's -- it benefits -- it's four-times improvement. but if you get the moderna, it's 76 times improvement and pfizer 35. i mean, that's incredible. >> right. and to be fair, antibody response is not the only measure of immune protection. you also have b cells and t cells that are involved in the immune response and the studies have not looked at effectiveness. as in they are not looking -- they are looking at how much do your antibodies increase? but not how well protected you are against covid-19 so it's not like the pfizer or moderna vaccines are many, many more times effective but you do get this very strong antibody response because antibody response is a correlate of immunity. i think it does -- it should give people a lot of pause at least to consider getting a second dose for people who got the johnson & johnson initial vaccine. >> dr. leana wen, appreciate it. thank you. >>> still ahead, new cnn polling revealing how americans feel about the job president biden is doing and wh

a second j&j? >> i do think this is a promising way to really increase immunity that people got from the j&j vaccine. the j&j vaccine used a different booster. and it's something if the j&j should think about getting, who got the j&j vaccine, to get boosted with an mrna. it's a way to mix the vaccines. >> just another mix and match question, if you got pfizer should you get the moderna, or vice versa? if you got moderna, get pfizer, completely mix it up or doesn't matter? >> moderna and pfizer both use the same technology. so i don't think there's great advantage to mixing pfizer and moderna. suppose you go to a drugstore and they don't have the one you have, it's okay to have that added version of that. these are all the same technologies, j&j and mrna vaccines are different technologies to stimulate parts of your immune system in different ways. >> we should also advise that it does take a couple weeks for any of these vaccines to take full effect. so do it sooner rather than later. as well as an

got that j & j vaccine, they are basically waiting to see what to do. the recommendations are going to be two months after that shot, at least, you should get a second shot, either j & j or the rna vaccine. the j & j was probably meant to be a two shot vaccine so getting a second one will raise immunity. getting an rna will raise it even more. >> on the top eck of mixing and matching which we are all curious about, which provides better protectioning, mixing and matching or the same vaccine for all doses. >> if we take antibody level as a surrogate for how much immunity you get, probably mixing gives you slightly better protection with slightly more side effects so i do think getting the same one is okay and will you get enough protection to get you through delta but if you want a little bit more protection, mixing may have some benefits. >> we see minnesota hitting another critical covid point with hospitalizations peaking again. is our countoin a er or worion as we year? >> you know, if i had that, i could win on vegas. but i certainly think now we're

. >> i'm choosing not to do j&j today. not because i had any problems with j&j. in fact, it went beautifully. but to make the point about the opportunity to mix and match. >> if you're eligible for a booster, state officials encourage that you get one, especially if you plan to gather with family and friends during holidays. last year you might recall we had a spike in cases during the holiday season. so is this shift the right call? or should we be focusing on getting the first and second doses to those people who are still hesitant? tonight we bring in our covid expert. the infectious disease expert at ucsf. nice to have you back on the program. really quick hear, there is availability from all the counties. that's what they're telling us. we do see some long lines and really some problems getting appointments. are you hearing any of that? >> no, i'm actually not hearing too many problems getting appointments. maybe the peak periods. i myself tried to make an appointment at a local walgreens. it was pretty easy when i did it, at least. i eventually ended up get

please welcome ll cool j! [cheers and applause] ♪ ♪ >> love, love. >> kelly: oh, my god, you look so nice. i like your suit. >> ll cool j: thank you. >> kelly: you look so good! >> ll cool j: i feel good. it is >> kelly: you should. it's great to see you in peon. it's been too great to see you too. we have been doing a lot of zooms a lot of suit tearing out a lot of screens. people in the building. what's up, real people? [cheers and applause] >> kelly: last time you were here you were giving fans or actual phone number because people were having problems during the pandemic. what was it like? did you get calls and texts? >> ll cool j: i got a couple of calls, and talking to people, birthdays, and just good vibes and energy, and when everybody was quarantined, i just wanted to make myself a little bit more available than i usually am and share some love and try to -- >> kelly: people need some. >> ll cool j: and that's what i did and it went well. >> kelly: how many people ask you out on a date? >> ll cool

j was better than giving those folks a second j&j shot. but the fda said it has not had time to review the data and advisers did not vote on it today. so it's unclear where the agency will include that flexibility in the decision on the boosters, which is expected to issue in about a week the cdc advisers are scheduled to meet on covid boosters thursday the committee also talked about increasing flexibility for the pfizer and moderna booster as well, which are now only recommended for high-risk groups beige, health condition or setting. based on new data from israel, they discussed broadening eligibility to everyone over age 40 or 50 they didn't have that same cutoff for j&j they recommended a second dose for everyone and many of the advisers even making clear they don't even necessarily consider it a booster vaccine scientist dr. paul offit saying, quote, i think this frankly was always a two-dose vaccine. as two doses two months apart was shown to increase vaccine efficacy for j&j more than 90%. >> 90%, that's a number, meg thank you. >>

j vaccine. or if you get a second dose that is an mrna vaccine. it is not saying that it doesn't work, but rather that you get additional protection with an additional dose of the vaccine. >> and that's what you chose to do. you chose to get a dose of a mrna vaccine of pfizer? >> that's right. and so i knew that i would need to get a second dose because the j&j vaccine probably should have been a two-dose vaccine. we didn't know that at the time when it was first being studied. now we know that probably get a second dose. i chose to get an mrna vaccine, because the j&j vaccine is associated with a very rare but very serious side effect of a blood clotting disorder that is predominantly seen in women under the age of 50. as a person in this category, i decided that the mrna vaccines do not have this potential side effect and i would rather do that. now, i realize that the cdc has not yet weighed in on this, they're weighing in on their meeting today, but i would expect they will also be allowing

j vaccine might say why get a j&j booster? should i wait and get pfizer or moderna in the future? what do you say to them? >> i think they should wait until there's more data. the studies presented at yesterday's fda vaccine advisory meeting involved about 50 people per group so that's a small study. you want to make sure there's no surprises. you'd like to see a larger data set before you move forward on that kind of recommendation. >> another thing i want to ask you about here, regulators are expected to address the pfizer vaccine for kids ages 5 to 11 by the end of the month. what do you hope to see in the data and what's your message to parents? >> so we'll be considering that on october 26th, the 5 to 11-year-old. you hope to see robust data of excellent immune responses and clear evidence of safety. we need a vaccine for children. i was on service last week and we had a number of children in our hospital including in the intensive care unit with covid, so we do need a vaccine for children but we need one that's safe and

as we await the fda and the cbc's decisions on potential moderna and j&j boosters in the coming days, we are working with our partners to prepare. we have the vaccine supply, and we are ready to hit the ground running as soon as any additional boosters are authorized. i will close with this, we are on the right track in our fight against the virus. two out of three eligible individuals, 188 million americans, are now fully vaccinated, with more americans getting vaccinated each day. the most vulnerable among us are getting extra protection from a booster. we have the tools, the resources, and the know-how to accelerate our path out of this pandemic. and we are not letting up. we are laser focused on getting more shots in arms, and we will keep using every available tool to protect people and keep following the science to stay ahead of the virus. but as the president has said from day one, we need everyone to do their part. so if you are unvaccinated or eligible for a booster, please go get a shot. it is free. it is safe. it is convenient. and it will protect you, your loved ones, and

higher than following a second j&j dose. so we await their decision tomorrow. >> all right, thank you so much. >>> could the supreme court expand? could it increase the number of justices? a commission set up by president biden just dropped its first draft materials moments ago. that story next. o and i don't fo those other family plans. that's why we love visible. they do things differently. yeah, it's wireless with unlimited data and if you join a group it's as low as $25/mo. all powered by verizon. 5g included. woo! just get together and save! we look goooood! what's everyone's handle? visible. unlimited data, as low as $25/mo all-in. powered by verizon, 5g included. wireless that gets better with friends. what makes new salonpas arthritis gel so good for arthritis pain? salonpas contains the most prescribed topical pain relief ingredient. it's clinically proven, reduces inflammation and comes in original prescription strength. salonpas. it's good medicine. >>> breaking news for you in our politics lead. just minutes ago

why such a short time frame for the j&j. >> that's the way it was tested. if this were not a pandemic this might have launched as a two-dose vaccine with the second dose two months apart. because many got the j&j awhile ago to say get it only two months later would exclude a lot of people. the recommendation is any time after two months which will then include virtually everybody. >> so speculated a lot of the people who chose the j&j vaccine did so because of convenience. it's obviously a lot easier to get one vaccine than two. maybe some of these people are in rural america. maybe some of these people are -- have very busy, demanding jobs, work two jobs, three jobs. are you worried that this push for a second shot for j&j will be harder to convince people to get because they are, by definition, one and done people? >> so the good news is that even a single dose induces immunological memory cells that are responsible for protecting against serious illness. we always talk about neutralizing antibodies. neutralizing antibodies fade over time but memory cells

well, the fed chair, jerome pal, i j. pow. he says, well, inflation is high and unemployment rate is high. so. right, right. a step to play, the fed has 2 jobs. one is full employment. the other is price stability. so there are failing on both of their primary jobs. and in a way that was predictable. because if you're simply printing money to bail out bankers all day long, you create a situation and what you do not have any reliable price discovery, amy economy for any of the components that make up the economy. this leads to both corruption and mal investment, a wealth and income gap. and as we see now, stagflation you have on employment high and inflation. those high in both of these things are now structural cyclical. they cannot be cured by simply extending and pretending they can. if the u. s. or to introduce 100 year bonds or 200 year bonds, that's not going to solve it. negative interest rates are not going to solve it. this is now pretty much heading toward a well catastrophe. yeah, and again, one analogy with made in

today's auction involve the j&j single shot vaccine. the fda advisor said the extra shot can be administered two months after the initial vaccination. you will get details after the news summary. the cdc said late today that international travelers who have received mixed doses of covid vaccines will be allowed to enter the country. attorneys for nicholas cruz said he will plead guilty to murdering 1people at a high school in parkland for the in 20 18. they announced it as he appeared at a court hearing today. he will also plead guilty to 17 counts of attempted murder at a hearing next week. they will decide if he gets the death penalty. in afghanistan, 47 people were killed today and 70 wounded when suicide bombers triggered a suicide bombing in kandahar. it came during friday prayers. they cleared away debris as witnesses described a coordinated strike. >> [speaking foreign language] >> after the attackers came, they threw a hand grenade. one blew himself up in the court and entered the mosque and detonated his explosive as they were

should people be thinking of the j&j as a two-dose vaccine now? >> yeah. and again, many folks thought this should have been a two-dose vaccine from the beginning. remember, the j&j vaccine uses an adenovirus vector to deliver the genetic material for the vaccine. it's similar to the astrazeneca vaccine, first used in the united kingdom, which is a two-dose vaccine. many people felt that the j&j vaccine probably should have been a two-dose vaccine. but from a marketing and positioning standpoint, johnson & johnson had a real interest in trying to have a unique vaccine that was one and done. unfortunately, it just doesn't seem to work optimally in that dosing schedule. everyone who received a johnson & johnson vaccine should get a second dose more than two months after the administration. the question is, however, when will we know from cdc and fda whether perhaps giving an mrna as a second dose to the j&j folks is a better strategy? there is suggested data that you can give a big boost to the j&j by adding pfizer or moderna as a second shot. >> so there's

j. still, moderna says its booster shot given at least six months after the second dose increased protective antibodies by 15-fold one month later. moderna also finding side effects from its booster were similar to those after first and second doses. and today, some panel members arguing the main focus should be on getting the 66 million eligible unvaccinated americans their first shot. >> the people who are in the icu aren't there because they haven't gotten the third dose, they're there because they haven't gotten any dose. >> reporter: tomorrow, the panel will review the johnson & johnson booster along with data on the effectiveness of mixing vaccines. an nih study also finding there could be an extra benefit for people who got the j&j vaccine to get a boost from pfizer or moderna. >> i think these early studies are pointing to the potential value mixing and matching but it's likely too early and we're going to really need more data to see sort of full recommendations. >> reporter: an